| 1/3 | US=22 / Câncer Copur MS, Rose M, Gettinger SN. Miscellaneous chemotherapeutic agents. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 490-5. AGENTES QUIMIOTERAPICOS; BLEOMYCIN; PROCARBAZINE; THALIDOMIDE; LENALIDOMIDE |
| 2/3 | US=11-B / Quimioterapia Kingsley CD. Hypersensitivity reactions. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 152-73. ISBN 978-0-7817-7328-7. REACOES DE HIPERSENSIBILIDADE; ASPARAGINASE; PEGASPARGASE; PACLITAXEL; DOCETAXEL; TENIPOSIDE; ETOPOSIDE; CISPLATINA; CARBOPLATINA; OXALIPLATINA; PROCARBAZINE; CITARABINA; ANTRACICLINA; CICLOFOSFAMIDA; IFOSFAMIDA; MELFALANO; CLORAMBUCIL; TIOTEPA; METOTREXATO; TRIMETREXATO; PEMETREXED; 5-FLUOROURACIL; CAPECITABINA; GEMCITABINA; MITOXANTRONA; MITOMICINA; BLEOMICINA; VINCRISTINA; VINBLASTINA; VINORELBINA; FLUDARABINA; CLADRIBINA; PENTOSTATINA; HIDROXIUREIA; IRINOTECAM; TOPOTECANO; DACARBAZINA; TEMOZOLAMIDA; 6-MERCAPTOPURINA; ALDESLEUCINA; DENILEUCINA DIFTITOX; INTERFERON ALFA; ANTICORPOS MONOCLONAIS; TIROSINA-QUINASE; INIBIDORES PROTEOSSOMICOS; TALIDOMIDA; LENALIDOMIDA; TERAPIA HORMONAL; FATORES DE CRESCIMENTO HEMATOPOETICOS |
| 3/3 | US=8 / Quimioterapia Friedman HS, Averbuch SD, Kurtzberg J. Nonclassic agents. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 310-31. ISBN 978-0-7817-5628-6. |